Associate Professor Martin Weltman

Associate Professor Medicine
Medicine, Nepean Clinical School

Nepean Hospital
The University of Sydney
NSW 2006 Australia

T: +61 4734 3332
F: 47343145
E:

Research interests

Associate Professor Weltman has several areas of research interest including

-Non-alcoholic fatty liver disease (NAFLD)(natural history, prognostic indicators, pathogenetic mechanisms and therapies

-Alcoholic hepatitis

-Clinical trials and therapy for chronic hepatitis C and B infection

-Genomics for HCV

-Therapies for inflammatory bowel disease

-Interventions for Barrett's oesophagus

-Epidemiology and natural hisrtory of functional dyspepsia and irritable bowel syndrome

Keywords

Substance abuse and addiction; Hepatitis; Obesity & overweight; Gastroenterology; Hepatology

International links

Australia. (University of Queensland) Fatty liver research.

Publications

2013 | 2012 | 2011 | 2010 | 2009 | 2008

2013

   
  • Kitson, M., Dore, G., George, J., Button, P., McCaughan, G., Crawford, D., Sievert, W., Weltman, M., Cheng, W., Roberts, S. (2013), Vitamin D status does not predict sustained virologic response or fibrosis stage in chronic hepatitis C genotype 1 infection. Journal of Hepatology. 58(3), 467-472. [Abstract]
  • Suppiah, V., Armstrong, N., O'Connor, K., Berg, T., Weltman, M., Abate, M., Spengler, U., Bassendine, M., Dore, G., Irving, W., Powell, E., Nattermann, J., Mueller, T., Riordan, S., Stewart, G., George, J., Booth, D., Ahlenstiel, G., Michalk, M., Malik, B., McClure, P., Smith, S., Sheridan, D., Snape, E., Fragomeli, V., Norris, R., How-Chow, D., Jonsson, J., Barrie, H., Stelzer-Braid, S., Fletcher, S., Applegate, T., Grebely, J., Matthews, G., Bharadwaj, M., Smedile, A. (2013), CCR5-Δ32 genotype does not improve predictive value of IL28B polymorphisms for treatment response in chronic HCV infection. Genes and Immunity. 14(5), 286-290. [Abstract]
  • Walsh, A., Weltman, M., Burger, D., Vivekanandarajah, S., Connor, S., Howlett, M., Radford-Smith, G., Selby, W., Veillard, A., Grimm, M., Travis, S., Lawrance, I. (2013), Implementing guidelines on the prevention of opportunistic infections in inflammatory bowel disease. Journal of Crohn's & Colitis. 7(10), e449-456. [Abstract]

2012

   
  • Gidding, H., Law, M., Amin, J., Ostapowicz, G., Weltman, M., Macdonald, G., Sasadeusz, J., Haber, P., George, J., Dore, G. (2012), Hepatitis C treatment outcomes in Australian clinics. Medical Journal of Australia. 196(10), 633-637. [Abstract]
  • Koloski, N., Jones, M., Kalantar, J., Weltman, M., Zaguirre, J., Talley, N. (2012), The brain-gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study. Gut. 61(9), 1284-1290. [Abstract]
  • Crawford, D., Dore, G., Sievert, W., Cheng, W., Weltman, M., McCaughan, G., Rawlinson, W., Marks, P., Yoshihara, M., Rizkalla, B., Roberts, S. (2012), Early on-treatment viral load and baseline METAVIR score: improved prediction of sustained virological response in HCV genotype 1 patients. Antiviral Therapy. 17(5), 849-854. [Abstract]

2011

   
  • Suppiah, V., Gaudieri, S., Armstrong, N., O'Connor, K., Berg, T., Weltman, M., Abate, M., Spengler, U., Bassendine, M., Dore, G., Irving, W., Powell, E., Hellard, M., Riordan, S., Matthews, G., Sheridan, D., Nattermann, J., Smedile, A., Müller, T., Hammond, E., Dunn, D., Negro, F., Bochud, P., Mallal, S., Ahlenstiel, G., Stewart, G., George, J., Booth, D. (2011), IL28B, HLA-C, and KIR Variants Additively Predict Response to Therapy in Chronic Hepatitis C Virus Infection in a European Cohort: A Cross-Sectional Study. PLoS Medicine. 8(9), e1001092. [Abstract]
  • Shim, L., Eslick, G., Simring, A., Murray, H., Weltman, M. (2011), The effects of azathioprine on birth outcomes in women with inflammatory bowel disease (IBD). Journal of Crohn's & Colitis. 5(3), 234-238. [Abstract]
  • Sasadeusz, J., Dore, G., Kronborg, I., Barton, D., Yoshihara, M., Weltman, M. (2011), Clinical Experience with the Treatment of Hepatitis C Infection in Patients on Opioid Pharmacotherapy. Addiction (Abingdon, England). 106(5), 977-84. [Abstract]
  • Sievert, W., Dore, G., McCaughan, G., Yoshihara, M., Crawford, D., Cheng, W., Weltman, M., Rawlinson, W., Rizkalla, B., Depamphilis, J., Roberts, S. (2011), Virological response is associated with decline in hemoglobin concentration during pegylated interferon and ribavirin therapy in hepatitis C virus genotype 1. Hepatology. 53(4), 1109-1117. [Abstract]
  • Baleriola, C., Rawlinson, W., Dore, G., Chaverot, S., Stelzer-Braid, S., Yoshihara, M., Crawford, D., Sievert, W., McCaughan, G., Weltman, M., Cheng, W., Rizkalla, B., Dubois, D., Thommes, J., Roberts, S. (2011), Effect of low-level HCV viraemia at week 24 on HCV treatment response in genotype 1 patients. Antiviral Therapy. 16(2), 173-180. [Abstract]
  • Dawes, G., Sitharthan, T., Conigrave, K., Phung, N., Weltman, M. (2011), Patients admitted for inpatient cannabis detoxification: withdrawal symptoms and impacts of common comorbidities. Journal of Substance Abuse. 16(5), 392-405.
  • Thomson, A., Kwok, R., Weltman, M. (2011), Genetic evaluation of polyposis. Current Colorectal Cancer Reports. 7(1), 8-15.
  • Smith, K., Suppiah, V., O'Connor, K., Berg, T., Weltman, M., Abate, M., Spengler, U., Bassendine, M., Matthews, G., Irving, W., Powell, E., Riordan, S., Ahlenstiel, G., Stewart, G., Bahlo, M., George, J., Booth, D. (2011), Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohort. Genome Medicine. 3(8), 57. [Abstract]

2010

   
  • Thomson, A., Weltman, M. (2010), Electronic images of the month. Severe duodenitis after massive chronic Ibuprofen overdose. Clinical Gastroenterology and Hepatology. 8(11), e114. [Abstract]
  • Cheng, W., Roberts, S., McCaughan, G., Sievert, W., Weltman, M., Crawford, D., Rawlinson, W., Marks, P., Thommes, J., Rizkalla, B., Yoshihara, M., Dore, G. (2010), Low virological response and high relapse rates in hepatitis C genotype 1 patients with advanced fibrosis despite adequate therapeutic dosing. Journal of Hepatology. 53(4), 616-623. [Abstract]
  • Milner, K., van der Poorten, D., Trenell, M., Jenkins, A., Xu, A., Smythe, G., Dore, G., Zekry, A., Weltman, M., Fragomeli, V., George, J., Chisholm, D. (2010), Chronic Hepatitis C is Associated with Peripheral rather than Hepatic Insulin Resistance. Gastroenterology. 138(3), 932-41.e1-3. [Abstract]

2009

   
  • Roberts, S., Weltman, M., Crawford, D., McCaughan, G., Sievert, W., Cheng, W., Rawlinson, W., Desmond, P., Marks, P., Yoshihara, M., Rizkalla, B., Depamphilis, J., Dore, G. (2009), Impact of high-dose peginterferon alfa-2A on virological response rates in patients with hepatitis C genotype 1: a randomized controlled trial. Hepatology. 50(4), 1045-1055. [Abstract]
  • Suppiah, V., Moldovan, M., Ahlenstiel, G., Berg, T., Weltman, M., Abate, M., Bassendine, M., Spengler, U., Dore, G., Powell, E., Riordan, S., Sheridan, D., Smedile, A., Fragomeli, V., Müller, T., Bahlo, M., Stewart, G., Booth, D., George, J. (2009), IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nature Genetics. 41(10), 1100-1104. [Abstract]
  • Brzozowska, M., Ostapowicz, G., Weltman, M. (2009), An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome. Journal of gastroenterology and hepatology. 24(2), 243-247. [Abstract]
  • Milne, B., Bell, J., Weltman, M., Lampropoulos, B., Towns, S. (2009), Alcohol, drugs and Australian young people. In: Challenges in Adolescent Health: An Australian Perspective. (pp.163-175).United States: Nova Science Publishers.

2008

   
  • Richardson, K., Baillie, A., Reid, S., Morley, K., Teesson, M., Sannibale, C., Weltman, M., Haber, P. (2008), Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol?. Addiction. 103(6), 953-959. [Abstract]
  • Weltman, M. (2008), Occult gastrointestinal bleeding and iron deficiency anemia. In: Gastroenterology and Hepatology: A Clinical Handbook. (pp.246-259).Australia: Elsevier Australia.
  • Talley, N., Weltman, M., Segal, I. (2008), Gastroenterology and Hepatology: a Clinical Handbook. Australia: Churchill Livingstone.
  • Darke, J., Weltman, M. (2008), Acute liver failure. In: Gastroenterology and Hepatology: A Clinical Handbook. (pp.491-501).Australia: Elsevier Australia.
  • Weltman, M. (2008), Obesity and Abnormal Liver Function Tests. In: Gastroenterology and Hepatology: A Clinical Handbook. (pp.411-420).Australia: Elsevier Australia.